SI2552910T1 - Novi polimorf - Google Patents

Novi polimorf

Info

Publication number
SI2552910T1
SI2552910T1 SI201130487T SI201130487T SI2552910T1 SI 2552910 T1 SI2552910 T1 SI 2552910T1 SI 201130487 T SI201130487 T SI 201130487T SI 201130487 T SI201130487 T SI 201130487T SI 2552910 T1 SI2552910 T1 SI 2552910T1
Authority
SI
Slovenia
Prior art keywords
new polymorph
polymorph
new
Prior art date
Application number
SI201130487T
Other languages
English (en)
Slovenian (sl)
Inventor
Johan Henrik KJELLSTROM
Bjorn Erik Johanson
Thomas Vilhelmsen
Original Assignee
Vantia Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vantia Limited filed Critical Vantia Limited
Publication of SI2552910T1 publication Critical patent/SI2552910T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
SI201130487T 2010-04-01 2011-03-31 Novi polimorf SI2552910T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1005623.2A GB201005623D0 (en) 2010-04-01 2010-04-01 New polymorph
US34704810P 2010-05-21 2010-05-21
PCT/GB2011/000500 WO2011121308A1 (en) 2010-04-01 2011-03-31 New polymorph
EP11714079.8A EP2552910B1 (en) 2010-04-01 2011-03-31 New polymorph

Publications (1)

Publication Number Publication Date
SI2552910T1 true SI2552910T1 (sl) 2015-06-30

Family

ID=42228830

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130487T SI2552910T1 (sl) 2010-04-01 2011-03-31 Novi polimorf

Country Status (20)

Country Link
US (1) US9079881B2 (enExample)
EP (1) EP2552910B1 (enExample)
JP (1) JP5802737B2 (enExample)
KR (1) KR101792621B1 (enExample)
CN (1) CN102918038B (enExample)
CA (1) CA2795109C (enExample)
DK (1) DK2552910T3 (enExample)
ES (1) ES2538085T3 (enExample)
GB (1) GB201005623D0 (enExample)
HR (1) HRP20150513T1 (enExample)
HU (1) HUE026442T2 (enExample)
ME (1) ME02102B (enExample)
MX (1) MX2012011382A (enExample)
PL (1) PL2552910T3 (enExample)
PT (1) PT2552910E (enExample)
RS (1) RS53956B1 (enExample)
RU (1) RU2559633C2 (enExample)
SI (1) SI2552910T1 (enExample)
SM (1) SMT201500107B (enExample)
WO (1) WO2011121308A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process
CN103755707B (zh) * 2013-09-17 2015-11-18 天津药物研究院 利希普坦晶型ⅱ及其制备方法和用途
CN104059070B (zh) * 2013-09-17 2016-02-10 天津药物研究院有限公司 利希普坦晶型ⅰ及其制备方法和用途
CN103694240B (zh) * 2013-09-18 2015-11-18 天津药物研究院 利希普坦的溶剂合物及其制备方法和用途
CN104140429B (zh) * 2014-07-25 2015-11-18 天津药物研究院 利希普坦晶型ⅴ及其制备方法和用途
EP4616852A3 (en) 2015-07-22 2025-10-22 Anavex Life Sciences Corp. Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW359669B (en) 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
ES2229523T3 (es) 1997-07-30 2005-04-16 Wyeth Agonistas triciclicos de la vasopresina.
IL133788A0 (en) 1997-07-30 2001-04-30 American Home Prod Tricyclic vasopressin agonists
WO2000046227A1 (en) 1999-02-04 2000-08-10 American Home Products Corporation Thienylbenzoylbenzazepines as vasopressin agonists
PT1149096E (pt) 1999-02-04 2003-03-31 Wyeth Corp N-oxidos de piridina triciclicos agonistas de vasopressina
WO2000046228A2 (en) 1999-02-04 2000-08-10 American Home Products Corporation Pyrrolobenzodiazepine carboxyamide vasopressin agonists
CN1339035A (zh) 1999-02-04 2002-03-06 美国家用产品公司 吡啶并苯并二吖庚因和吡啶并苯并氧杂吖庚因酰胺血管加压素激动剂
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents

Also Published As

Publication number Publication date
KR101792621B1 (ko) 2017-11-02
HUE026442T2 (en) 2016-06-28
RU2012146544A (ru) 2014-05-10
RU2559633C2 (ru) 2015-08-10
KR20130023218A (ko) 2013-03-07
CA2795109A1 (en) 2011-10-06
GB201005623D0 (en) 2010-05-19
JP2013523706A (ja) 2013-06-17
DK2552910T3 (en) 2015-04-07
ME02102B (me) 2015-10-20
CN102918038A (zh) 2013-02-06
PL2552910T3 (pl) 2015-07-31
CA2795109C (en) 2018-04-17
HRP20150513T1 (hr) 2015-06-05
SMT201500107B (it) 2015-07-09
MX2012011382A (es) 2013-01-29
US20140296213A1 (en) 2014-10-02
EP2552910A1 (en) 2013-02-06
EP2552910B1 (en) 2015-03-11
RS53956B1 (sr) 2015-08-31
US9079881B2 (en) 2015-07-14
WO2011121308A1 (en) 2011-10-06
ES2538085T3 (es) 2015-06-17
CN102918038B (zh) 2015-09-09
PT2552910E (pt) 2015-05-13
JP5802737B2 (ja) 2015-11-04

Similar Documents

Publication Publication Date Title
GB201007286D0 (en) New compounds
GB201020179D0 (en) New compounds
AP2012006641A0 (en) New compounds
IL223783A0 (en) Pro-neurogenic compounds
GB201008134D0 (en) Compounds
GB201015949D0 (en) Compounds
IL221901A0 (en) Morpholinylquinazolines
AP2012006640A0 (en) New aminopyrazoloquinazolines
PL2619208T3 (pl) Związki imidazotriazynonu
GB201007347D0 (en) Compounds
GB201112745D0 (en) New uses
EP2649050A4 (en) LINKS
GB201012686D0 (en) Novel compounds
GB201002563D0 (en) Compounds
PT2552910E (pt) Novo polimorfo
GB201008209D0 (en) Compounds
GB201001688D0 (en) Compounds
GB201001796D0 (en) Compounds
GB201002216D0 (en) Compounds
GB201015537D0 (en) Compounds
GB201008210D0 (en) Compounds
GB201021494D0 (en) Compounds
GB201013507D0 (en) Compounds
GB201012899D0 (en) New compounds
GB201004307D0 (en) New compounds